merged_eu-covid-vaccines.txt
<question_number>1</question_number>
<answer>The ruling gives new momentum to Ursula von der Leyen's critics ahead of a tight vote and may make it harder for her to secure votes from lawmakers like the Greens, who were already incensed by her handling of the crisis and whose support she likely needs.</answer>
<question_number>2</question_number>
<answer>The article implies that the lack of transparency in the vaccine purchasing strategy contributed to a sense of distrust among European voters about how officials spent taxpayer money, which occurred amid a surge in far-right politicians.</answer>
<question_number>3</question_number>
<answer>It has incensed center-left lawmakers, including the Greens, whose votes she will most likely need to win a second term.</answer>
<question_number>4</question_number>
<answer>The article implies that the lack of transparency in the vaccine procurement strategy has contributed to a sense of distrust among European voters about the use of taxpayer money, a sentiment that has grown at the same time as a surge in far-right politicians.</answer>
<question_number>5</question_number>
<answer>The ruling validates concerns about a lack of transparency, which the article states have contributed to a sense of distrust among European voters amid a recent surge in far-right politicians.</answer>
<question_number>6</question_number>
<answer>The ruling came just ahead of an expected tight vote on her future, giving new momentum to her critics.</answer>
<question_number>7</question_number>
<answer>The EU's strategy shifted from an initial slow, conservative, budget-conscious approach to a massive procurement that later led to concerns of ordering too many vaccines and causing waste.</answer>
<question_number>8</question_number>
<answer>The European Commission's statement claimed it had provided the European Parliament "full information," which contradicts the court's finding that it wrongly withheld information and redacted purchasing agreements.</answer>
<question_number>9</question_number>
<answer>Both the ruling and The New York Times' case are about freedom of information and transparency regarding the EU's Covid-19 vaccine deals, and The New York Times welcomed the ruling as reinforcing this principle.</answer>
<question_number>10</question_number>
<answer>The ruling is likely to reinforce public distrust about how officials spent taxpayer money during the pandemic, as it validates concerns about a lack of transparency.</answer>